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We report a boy, who achieved developmental milestones
without delay, presenting complex partial seizures (left-
deviation of the head, staring gaze, oral automatism and
tonic-clonic generalization) at 7 years: his blood/cerebro-
spinal fluid tests were all within normal limits, enclosed
those for inborn errors of metabolism. Progressive signs
of psycho-motor regression were simultaneously
observed by caregivers in combination with a band of lin-
ear ivory-coloured indurated lesion on the dorsal region
of the right foot, which was diagnosed as linear localized
scleroderma (LS). Immunological tests performed at 8
years revealed only low-titre positivity of anti-nuclear
antibodies. Various brain CT and MRI scans resulted neg-
ative. In the following years tonic-clonic seizures were
observed with daily recurrence in spite of different antiep-
ileptic drugs. At 16 years we evaluated this patient for the
first time: asymmetrical tonic fits had multiple daily fre-
quency and therapy consisted of clobazam/methsux-
imide; EEG revealed dysrupted electrical cerebral activity;
brain MRI was normal; the skin lesion was extended to the
whole right inferior limb. Methotrexate (MTX) and pred-
nisone were instituted (respectively at the dosage of 15
mg/m2/week and 1.5 mg/kg/day): MTX was maintained
for 1,5 year with low-dose prednisone (0.5 mg/kg/day).
Semeiological features of seizures remained unchanged
and no control upon their frequency could be reached,
whilst LS remained stable.
The exact nature of multi-resistant epilepsy associated
with extra-cranial linear LS remains a matter of debate and
the immunologic process leading to the pathologic colla-
gen deposition might be dissociated from the specific
neurological disturbance.
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